Wolverine Asset Management LLC Novavax Inc Call Options Transaction History

Wolverine Asset Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 01, 2023	BUY	$8.86 - $25.04 $50,502 - $142,728	5,700 Added 36.31%	21,400 $219,000
Q2 2022 Aug 03, 2022	BUY	$36.28 - $75.29 $362,800 - $752,900	10,000 Added 175.44%	15,700 $807,000
Q1 2022 May 04, 2022	BUY	$69.73 - $142.9 $390,488 - $800,240	5,600 Added 5600.0%	5,700 $419,000
Q1 2021 May 13, 2021	BUY	$112.98 - $319.93 $11,298 - $31,993	100 New	100 $18,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.